Science Current Events | Science News | Brightsurf.com
 

HIV Current Events | HIV News | 5

Sort By: Page Views | Date
Why were the HIV prevention trials in commercial sex workers abandoned?
One promising approach to help stem the global HIV epidemic is to give commercial sex workers an HIV medication (such as the drug tenofovir) before they have high risk sex in the hope of reducing their chances of becoming infected, an approach called "pre-exposure prophylaxis" (PREP).   view more (2005-07-19)

International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced that enrollment into a large international HIV/AIDS trial comparing continuous antiretroviral therapy with episodic drug treatment guided by levels of CD4+ cells has... view more (2006-01-18)

Protein from the wrong side of the tracks aids cancer virus
A protein made by a cancer-causing virus using an unusual gene enables that virus to infect immune cells and persist in the host, new research shows.   view more (2006-06-12)

Male circumcision 'could prevent millions of AIDS deaths'
Researchers involved with a 'landmark' trial, which found evidence that male circumcision (MC) could reduce the chance of becoming infected with HIV, have published an analysis estimating the likely impact of expanding the practice of MC across Africa.   view more (2006-07-11)

Researchers disprove 'fat redistribution syndrome' among men taking HIV drugs
There is no syndrome that causes increased belly fat and decreased facial and limb fat among HIV-positive men who take antiretroviral drugs.   view more (2005-10-14)

UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery
UC Davis researchers have discovered that the human immunodeficiency virus, the virus that causes AIDS, is able to survive efforts to destroy it by hiding out in the mucosal tissues of the intestine.   view more (2006-07-31)

Drug to Block Mother-to-Child HIV Transmission Induces Resistance
The incidence of drug resistance associated with single-dose nevirapine, a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the... view more (2005-06-02)

Autoimmune overload may damage HIV-infected brain
Researchers studying the evolution of the human immunodeficiency virus (HIV) in the brain have found that the body's own defenses may cause HIV-related dementia.   view more (2005-09-30)

Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
An antibiotic commonly used to treat a variety of serious infections may also help prevent dementia in HIV patients, according to a test-tube study of human brain cells by Johns Hopkins University School of Medicine neurologist Jeffrey Rumbaugh, M.D., Ph.D.   view more (2006-04-06)

Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have identified a previously unknown function of APOBEC3G (A3G), a protein that acts against HIV, a finding that may lead to new approaches for controlling HIV infection.   view more (2006-10-03)

Markers found for bacterial vaginosis
Findings reported in this week's New England Journal of Medicine (November 3 issue) highlight promising findings from two Seattle-based researchers on the origins of bacterial vaginosis (BV).   view more (2005-11-08)

Einstein scientists treat cancer as an infectious disease -- with promising results
Researchers at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that cancers can be successfully treated by targeting the viruses that cause them.   view more (2007-10-31)

New HIV statistics indicate increasing toll of AIDS on African American community
The country's leading African-American lawmakers, civil rights leaders and medical experts today called on the federal government to adopt and implement a new blueprint to address the HIV/AIDS crisis in the African-American community.   view more (2006-11-17)

Immune deficiency linked to a type of eye cancer
The incidence of squamous cell eye cancer is greater among kidney transplant patients and people with human immunodeficiency virus (HIV) than the general public, which suggests the disease is associated with immune deficiency.   view more (2007-08-15)

Researchers reveal key human protein's structure, promising new discoveries for leukemia, AIDS and cellular calcium release
Cornell University researchers have discovered the 3-D crystal structure of a protein, human CD38, which may lead to important discoveries about how cells release calcium - a mineral used in almost every cellular process.   view more (2005-09-20)

Anti-HIV drugs unlikely to stop HIV spread
Researchers believe antiretroviral therapy (ART) will not be effective in stopping HIV epidemics even if it is made universally available in poorer countries, and that widespread use could even lead to an increase in the numbers infected with HIV.   view more (2006-03-14)

Injection of synthetic polymer may improve facial wasting syndrome associated with HIV
Facial injections of polylactic acid, a synthetic biodegradable polymer, may help improve the debilitating facial lipoatrophy (loss of fat in the face) associated with HIV infection and its treatment.   view more (2006-03-21)

Circumcision: A proven strategy to prevent HIV
Male circumcision significantly reduces the risk of acquiring HIV in young African men, according to a study led by University of Illinois at Chicago professor of epidemiology Robert Bailey.   view more (2007-02-23)

Patients with history of cancer at increased risk for acquiring and dying from sepsis
Hospitalized patients with a history of cancer are at a ten-fold increased risk of acquiring and subsequently dying from sepsis— a severe immune response to an infection—compared to hospitalized patients without cancer.   view more (2006-06-14)

DNA chunks, chimps and humans
Researchers have carried out the largest study of differences between human and chimpanzee genomes, identifying regions that have been duplicated or lost during evolution of the two lineages.   view more (2008-11-06)

Ethnic differences in response to HIV medicines
Researchers from the University of Massachusetts and the University of Pennsylvania have shown that race/ethnicity is a predictor of plasma lipids in patients with HIV-1 on HAART (highly active antiretroviral therapy).   view more (2006-01-24)

Compound has potential for new class of AIDS drugs
Researchers have developed what they believe is the first new mechanism in nearly 20 years for inhibiting a common target used to treat all HIV patients, which could eventually lead to a new class of AIDS drugs.   view more (2008-05-15)

Criminalizing HIV transmission is a threat to public health, say experts
Experts in this week's BMJ express serious concerns about the public health impact of criminalising HIV transmission.   view more (2006-09-29)

Quality not quantity important for immune response to HIV
When it comes to an immune response against HIV, research funded by the Wellcome Trust in the UK and the National Institutes of Health in the US has found that bigger is not necessarily better, contrary to conventional medical wisdom.   view more (2006-12-18)

Computational model simulates AZT metabolism in mitochondria
Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed a computational model that allows scientists to better understand the metabolism and toxicity of the HIV/AIDS drug zidovudine (azidothymidine, AZT).   view more (2006-07-25)

Sort By: Page Views | Date
© 2008 BrightSurf.com